Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon H Preskorn

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Journal of Psychiatric Practice|May 24, 2012
Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: part 1Sheldon H Preskorn
Journal of Psychiatric Practice|March 3, 2022
How Loading Dose Strategies for Depot Paliperidone Can Go WrongSheldon H Preskorn
Journal of Psychiatric Practice|September 7, 2023
Eight Clinical Cases and the Lessons They TaughtSheldon H Preskorn
Journal of Psychiatric Practice|January 6, 2022
An Individual With 2 Distinct Nonpathologic IdentitiesSheldon H Preskorn
Journal of Psychiatric Practice|January 11, 2017
Use of an Analog Scale in the Treatment of Patients With Bipolar Disorder to Optimize Assessment and Clinical OutcomeSheldon H Preskorn
Journal of Psychiatric Practice|May 27, 2006
Patient with bipolar disorder and familial QT prolongation: what to do?Sheldon H Preskorn
Journal of Psychiatric Practice|July 7, 2022
Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug DevelopmentSheldon H Preskorn
Journal of Psychiatric Practice|August 28, 2004
Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitorSheldon H Preskorn
Journal of Psychiatric Practice|September 14, 2004
Tianeptine: a facilitator of the reuptake of serotonin and norepinephrine as an antidepressant?Sheldon H Preskorn
Journal of Psychiatric Practice|November 19, 2014
CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part ISheldon H Preskorn
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Journal of Psychiatric Practice|May 24, 2012
Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: part 1Sheldon H Preskorn
Journal of Psychiatric Practice|March 3, 2022
How Loading Dose Strategies for Depot Paliperidone Can Go WrongSheldon H Preskorn
Journal of Psychiatric Practice|September 7, 2023
Eight Clinical Cases and the Lessons They TaughtSheldon H Preskorn
Journal of Psychiatric Practice|January 6, 2022
An Individual With 2 Distinct Nonpathologic IdentitiesSheldon H Preskorn
Journal of Psychiatric Practice|January 11, 2017
Use of an Analog Scale in the Treatment of Patients With Bipolar Disorder to Optimize Assessment and Clinical OutcomeSheldon H Preskorn
Journal of Psychiatric Practice|May 27, 2006
Patient with bipolar disorder and familial QT prolongation: what to do?Sheldon H Preskorn
Journal of Psychiatric Practice|July 7, 2022
Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug DevelopmentSheldon H Preskorn
Journal of Psychiatric Practice|August 28, 2004
Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitorSheldon H Preskorn
Journal of Psychiatric Practice|September 14, 2004
Tianeptine: a facilitator of the reuptake of serotonin and norepinephrine as an antidepressant?Sheldon H Preskorn
Journal of Psychiatric Practice|November 19, 2014
CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part ISheldon H Preskorn
Pageof 20